All Articles by Author:

Justin.choi

Adverum Biotechnologies Doses First Patient in Cohort 4 of OPTIC Phase I Clinical Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD

[Adverum Biotechnologies, Inc.] Adverum Biotechnologies, Inc. announced that the first patient was dosed in Cohort 4 of the ongoing OPTIC Phase I clinical trial for ADVM-022 for the treatment of wet age-related macular degeneration (AMD).

Open Science Takes On the Coronavirus Pandemic

[Nature Technology Feature] When reports emerged in late 2019 of an outbreak of a new coronavirus centred in Wuhan, China, researchers at the virological-analysis website Nextstrain were ready. The open-source project tracks the spread of viruses through genetic variations in the sequences that scientists find.

Director of US Agency Key to Vaccine Development Leaves Role Suddenly Amid Coronavirus Pandemic

[STAT News] Rick Bright, one of the nation’s leading vaccine development experts and the director of the Biomedical Advanced Research and Development Authority, is no longer leading the organization.

Popular

ACSS1-Dependent Acetate Utilization Rewires Mitochondrial Metabolism to Support AML and Melanoma Tumor Growth and Metastasis

[Cell Reports] Scientists reported that acetyl-CoA synthetases (ACSS) 1 and 2 were differentially expressed in cancer. ACSS1 knockdown decreased acute myeloid leukemia burden in vivo and inhibited melanoma tumor and metastatic growth.

Sanofi, A*STAR, and the National Skin Centre Partner to Advance Research in Acne Treatment

[A*STAR] Sanofi, the Agency for Science, Technology and Research (A*STAR), and the National Skin Centre Singapore established a Memorandum of Understanding to advance research in acne treatment. This collaboration will encompass a Phase I clinical study in patients with mild acne.

RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction

[RTI Surgical] RTI Surgical announced the enrollment of the first patient in ADMIRE. This IDE study is designed to confirm the safety and effectiveness of Cortiva® Allograft Dermis in implant-based breast reconstruction.